Labena Ventures operates as a global accelerator and venture capital firm focusing on Biotech, Healthtech, Pharmatech, Food, and Environment sectors, primarily within the Central and Eastern Europe (CEE) region. Their core strategy involves identifying high-potential startups and providing them with a structured path to investment readiness, fundraising, and Minimum Viable Product (MVP) development. This involves offering access to mentorship from over 140 experts, potential business contacts, and a network of investors, fostering a community of founders. They aim to empower CEE startups to scale globally by connecting them with international business opportunities, customized programs, and dedicated experts. Labena Ventures facilitates this through a multi-stage program consisting of a Bootcamp, Acceleration phase, and Demo Day. The Bootcamp is a three-day interactive learning experience tailored for startups in their focused sectors, providing up-skilling opportunities with industry experts and early adopters. The Acceleration phase is a more intensive three-month program focused on business scaling through mentor interactions and investor connections. Demo Day provides an opportunity for startups to pitch their product and raise funds. Beyond the structured program, Labena Ventures emphasizes ongoing support through its Alumni Growth program, which involves exclusive networking events, access to special deals, and continued mentorship. They actively seek startups with scalable services or products, particularly those that can disrupt the Biotech, Healthtech, and Pharmatech landscape. Labena Ventures also seems to be involved in specific events like the Slovenia Business Bridge, connecting startups with global investors and providing opportunities for live pitches and potential funding. Recent investments and activities, based on the blog posts, involve companies like Neo Pill (revolutionizing oral hygiene for orthodontic patients), FilamenTech (new approach in heart disease drug discovery), and CAPTEC Medical (pioneering approach to combat cancer). These examples reflect their interest in innovative solutions within the healthcare and biotech sectors, and also serve as examples of companies that have benefitted from their accelerator program and investment.
Bevorzugte Reifephase für die erste Finanzierung.
Biotech, Healthtech, Pharmatech, Food, Environment
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
